23 results
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
and pharmaceutical experience also includes roles in business development, marketing, medical affairs, training, corporate communications, and investor
PRE 14A
CMRA
Comera Life Sciences Holdings, Inc.
1 Aug 23
Preliminary proxy
5:08pm
. McCourt’s prior biotechnology and pharmaceutical experience also includes roles in business development, marketing, medical affairs, training, corporate
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
clinical trials and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side … or retaining qualified personnel across functions that we deem critical to our success. Recruiting, training and retention difficulties can limit our
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side effects of our product … personnel across functions that we deem critical to our success. Recruiting, training and retention difficulties can limit our ability to support our
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:32pm
clinical trials and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side effects … or retaining qualified personnel across functions that we deem critical to our success. Recruiting, training and retention difficulties can limit our ability
424B3
doez a9fq
14 Nov 22
Prospectus supplement
5:19pm
424B3
js03p2krw07y
14 Nov 22
Prospectus supplement
5:15pm
424B3
ue1wvia8
14 Nov 22
Prospectus supplement
5:09pm
424B3
lblkc w9vv8logets9i5
14 Nov 22
Prospectus supplement
4:50pm
424B3
33hpw nc2nb
15 Sep 22
Prospectus supplement
4:09pm
424B3
d57 x5x6a
15 Aug 22
Prospectus supplement
5:45pm
10-Q
948kw zl4p
15 Aug 22
Quarterly report
4:53pm
424B3
d19cew
28 Jun 22
Prospectus supplement
10:45am
S-1
lqc0r
4 May 22
IPO registration
9:23pm
424B3
1q85852ddpt
15 Apr 22
Prospectus supplement
11:45am